La. Stephens et Twh. Kay, PANCREATIC EXPRESSION OF B7 COSTIMULATORY MOLECULES IN THE NONOBESE DIABETIC MOUSE, International immunology, 7(12), 1995, pp. 1885-1895
Expression of the co-stimulatory molecule B7-1 (CD80) on pancreatic be
ta cells can overcome peripheral T cell tolerance in transgenic models
of autoimmune disease. This study aimed to determine if aberrant B7-1
or B7-2 (CD86) expression on pancreatic beta cells is involved in the
pathogenesis of autoimmune diabetes in non-obese diabetic (NOD) mice.
Immunohistochemical analysis of NOD pancreas sections revealed no evi
dence of B7-1 or B7-2 expression on pancreatic beta cells at any stage
prior to the onset of either spontaneously arising or cyclophosphamid
e-accelerated diabetes. Likewise, the NOD-derived NIT-1 beta cell line
did not express surface B7 or B7-1 mRNA either constitutively or foll
owing exposure to IFN-gamma and TNF-alpha, two cytokines known to be p
resent in the insulitis lesion of NOD mice, or cAMP which can induce B
7-1 expression on B cells. Both B7-1 and B7-2 were, however, highly ex
pressed on the majority of islet-infiltrating inflammatory cells in NO
D mice between days 7 and 12 after the administration of cyclophospham
ide which results in accelerated beta cell destruction. Likewise B7-1
and B7-2 were extensively expressed on islet-infiltrating cells presen
t at the time of diabetes onset in NOD SCID mice with adoptively trans
ferred diabetes. By immunohistochemisty and flow cytometry, it was det
ermined that the phenotype of B7(+) cells in the pancreas of NOD mice
9 days after cyclophosphamide included a mixture of macrophages and bo
th CD4(+) and CD8(+) T cells. B7-2 was also expressed on islet-infiltr
ating cells in the spontaneously occurring diabetes of female NOD mice
, but the levels of B7-1 expression were low in comparison with the ac
celerated models of diabetes. RIP-IL-2 transgenic mice, which have ext
ensive islet infiltration but no autoimmune beta cell destruction, als
o had virtually no B7-1 expression and a minority of B7-2-expressing i
nflammatory cells. Thus, the activation of beta cell-specific T cells
in NOD mice does not appear to be a result of aberrant expression of B
7 on the beta cells. Expression of B7-1 and B7-2 on islet-infiltrating
cells is, however, associated with autoimmune beta cell destruction,
suggesting a role for the B7-CD28 interaction in this process.